<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>3 December 2013_x000b__x000b_Cancer Research UK submission to the Public Administration Select Committee inquiry into Charity Chief Executive Pay</title></head><body><div><p style="margin:0pt; text-align:right"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:right"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:center"><br /><br /><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Written Evidence from </span><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Cancer Research UK [CEP0007]</span></p><p style="margin:0pt 0pt 10pt; text-align:center"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Calibri; font-size:12pt; font-weight:normal; margin:0pt 0pt 0pt 14.11pt; padding-left:0.09pt; text-indent:0pt"><span style="font-family:Calibri; font-size:12pt">Cancer Research</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">UK </span><span style="font-family:Calibri; font-size:12pt">welcome</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> the opportunity to submit written evidence</span><span style="font-family:Calibri; font-size:12pt"> to the Public Administration Select Committee inquiry into charity chief executive pay. Cancer Research </span><span style="font-family:Calibri; font-size:12pt">UK is committed to transparency and ensuring that the public can continue to have high levels of confidence in </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">work.</span><br /><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></li></ol><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Background</span><br /><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Calibri; font-size:12pt; font-weight:normal; margin:0pt 0pt 0pt 14.11pt; padding-left:0.09pt; text-indent:0pt"><span style="font-family:Calibri; font-size:12pt">Cancer Research</span><span style="font-family:Calibri; font-size:12pt"> UK is the largest fundraising c</span><span style="font-family:Calibri; font-size:12pt">harity in the UK by some margin, </span><span style="font-family:Calibri; font-size:12pt">raising £460 million in 2012/13.</span><span style="font-family:Calibri; font-size:12pt">  </span><span style="font-family:Calibri; font-size:12pt">Its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">mission is to save lives from cancer.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">It is</span><span style="font-family:Calibri; font-size:12pt"> the largest charitable funder of cancer research in the world, funding more than half of all UK cancer rese</span><span style="font-family:Calibri; font-size:12pt">ar</span><span style="font-family:Calibri; font-size:12pt">ch. </span><span style="font-family:Calibri; font-size:12pt">Its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">life-saving work relies on the money donated by </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">supporters; </span><span style="font-family:Calibri; font-size:12pt">it</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">receive</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> no Government funding for </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">research.  </span></li></ol><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">3</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">              </span><span style="font-family:Calibri; font-size:12pt">Cancer Research UK</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">ha</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> a responsibility to </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">supporters</span><span style="font-family:Calibri; font-size:12pt">, </span><span style="font-family:Calibri; font-size:12pt">partners</span><span style="font-family:Calibri; font-size:12pt"> and employees, amongst others,</span><span style="font-family:Calibri; font-size:12pt"> to ensure that </span><span style="font-family:Calibri; font-size:12pt">it</span><span style="font-family:Calibri; font-size:12pt"> ha</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> strong and effective leadership to deliver the </span><span style="font-family:Calibri; font-size:12pt">best </span><span style="font-family:Calibri; font-size:12pt">outcomes for</span><span style="font-family:Calibri; font-size:12pt"> the public,</span><span style="font-family:Calibri; font-size:12pt"> for</span><span style="font-family:Calibri; font-size:12pt"> cancer patients and </span><span style="font-family:Calibri; font-size:12pt">for </span><span style="font-family:Calibri; font-size:12pt">their families.</span><br /><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">4</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">              </span><span style="font-family:Calibri; font-size:12pt">Cancer Research UK is a complex organisation</span><span style="font-family:Calibri; font-size:12pt">;</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">the appendix</span><span style="font-family:Calibri; font-size:12pt"> sets out</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">information about </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> scale and work </span><span style="font-family:Calibri; font-size:12pt">to contextualise </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> dec</span><span style="font-family:Calibri; font-size:12pt">isions and </span><span style="font-family:Calibri; font-size:12pt">procedures for remuneration. </span><br /><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt 14.2pt; orphans:0; page-break-after:avoid; page-break-inside:avoid; text-indent:-14.2pt; widows:0"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 10pt 14.2pt; orphans:0; page-break-after:avoid; page-break-inside:avoid; text-indent:-14.2pt; widows:0"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Return on fundraising income</span></p><p style="margin:0pt 0pt 10pt 14.2pt; orphans:0; page-break-after:avoid; page-break-inside:avoid; text-indent:-14.2pt; widows:0"><span style="font-family:Calibri; font-size:12pt">5</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">For every pound donated in 2012/13, 8</span><span style="font-family:Calibri; font-size:12pt">2</span><span style="font-family:Calibri; font-size:12pt"> pence was available to spend </span><span style="font-family:Calibri; font-size:12pt">on </span><span style="font-family:Calibri; font-size:12pt">Cancer Research UK’s</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">work towards </span><span style="font-family:Calibri; font-size:12pt">beating cancer.</span><span style="font-family:Calibri; font-size:12pt"> The balance of 18 pence</span><span style="font-family:Calibri; font-size:12pt"> was used to raise funds for the future through fundraising activities </span><span style="font-family:Calibri; font-size:12pt">such as</span><span style="font-family:Calibri; font-size:12pt"> Race for Life events. </span><span style="font-family:Calibri; font-size:12pt">Investing in fundraising</span><span style="font-family:Calibri; font-size:12pt"> is</span><span style="font-family:Calibri; font-size:12pt"> essential to sustaining income and </span><span style="font-family:Calibri; font-size:12pt">the Charity’s</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">ability to plan and fun</span><span style="font-family:Calibri; font-size:12pt">d research for the long term. </span><span style="font-family:Calibri; font-size:12pt">The Charity</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">st</span><span style="font-family:Calibri; font-size:12pt">rive</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> for efficiency in the way </span><span style="font-family:Calibri; font-size:12pt">it</span><span style="font-family:Calibri; font-size:12pt"> work</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> to ensure </span><span style="font-family:Calibri; font-size:12pt">that</span><span style="font-family:Calibri; font-size:12pt"> supporters’</span><span style="font-family:Calibri; font-size:12pt"> money </span><span style="font-family:Calibri; font-size:12pt">is used </span><span style="font-family:Calibri; font-size:12pt">as wisely as possible. </span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Employees</span><span style="font-family:Calibri; font-size:12pt; font-weight:bold"> and volunteers</span><br /><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">6</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">Cancer Research UK </span><span style="font-family:Calibri; font-size:12pt">has </span><span style="font-family:Calibri; font-size:12pt">more than</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">3,460 employees working across the UK</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">It</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">pay</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> the salaries of up to a further 4,000 scientists</span><span style="font-family:Calibri; font-size:12pt">,</span><span style="font-family:Calibri; font-size:12pt"> doctors</span><span style="font-family:Calibri; font-size:12pt">,</span><span style="font-family:Calibri; font-size:12pt"> nurses </span><span style="font-family:Calibri; font-size:12pt">and technicians </span><span style="font-family:Calibri; font-size:12pt">employed within universities and hospitals</span><span style="font-family:Calibri; font-size:12pt">.  A large proportion of </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">£100 million</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">salary budget </span><span style="font-family:Calibri; font-size:12pt">is dedicated to</span><span style="font-family:Calibri; font-size:12pt"> funding th</span><span style="font-family:Calibri; font-size:12pt">ose</span><span style="font-family:Calibri; font-size:12pt"> scientists whose skills and knowledge are cen</span><span style="font-family:Calibri; font-size:12pt">tral </span><span style="font-family:Calibri; font-size:12pt">to</span><span style="font-family:Calibri; font-size:12pt"> working towards </span><span style="font-family:Calibri; font-size:12pt">the Charity’s</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">mission</span><span style="font-family:Calibri; font-size:12pt"> of</span><span style="font-family:Calibri; font-size:12pt"> beat</span><span style="font-family:Calibri; font-size:12pt">ing</span><span style="font-family:Calibri; font-size:12pt"> cancer.  </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">7</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">Great research scientists</span><span style="font-family:Calibri; font-size:12pt"> are at the heart of groundbreaking cancer research. </span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">As a leading</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">organisation</span><span style="font-family:Calibri; font-size:12pt"> in the field of medical research</span><span style="font-family:Calibri; font-size:12pt">, it is essential that Cancer Research UK </span><span style="font-family:Calibri; font-size:12pt">attract</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> and retain</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">researchers</span><span style="font-family:Calibri; font-size:12pt"> of the highest quality to achieve its mission of beating cancer</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">It</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">remunerate</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> scientists according to established UK academic scales</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">M</span><span style="font-family:Calibri; font-size:12pt">any </span><span style="font-family:Calibri; font-size:12pt">are </span><span style="font-family:Calibri; font-size:12pt">highly skilled experts</span><span style="font-family:Calibri; font-size:12pt"> in their respective fields</span><span style="font-family:Calibri; font-size:12pt"> and </span><span style="font-family:Calibri; font-size:12pt">are internationally re</span><span style="font-family:Calibri; font-size:12pt">cognised </span><span style="font-family:Calibri; font-size:12pt">for the high quality of their research</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">&#xa0;</span><span style="font-family:Calibri; font-size:12pt"> </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">8</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">The Charity </span><span style="font-family:Calibri; font-size:12pt">also </span><span style="font-family:Calibri; font-size:12pt">ha</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">more than</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">41,000 volunteers who generously give their time to Cancer Research UK, </span><span style="font-family:Calibri; font-size:12pt">making</span><span style="font-family:Calibri; font-size:12pt"> a vital contribution</span><span style="font-family:Calibri; font-size:12pt"> towards the </span><span style="font-family:Calibri; font-size:12pt">C</span><span style="font-family:Calibri; font-size:12pt">harity’s achievements.  </span><span style="font-family:Calibri; font-size:12pt">V</span><span style="font-family:Calibri; font-size:12pt">olunteers </span><span style="font-family:Calibri; font-size:12pt">undertake</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">a diverse </span><span style="font-family:Calibri; font-size:12pt">range of roles</span><span style="font-family:Calibri; font-size:12pt">,</span><span style="font-family:Calibri; font-size:12pt"> with</span><span style="font-family:Calibri; font-size:12pt"> over 17,500 in our </span><span style="font-family:Calibri; font-size:12pt">retail </span><span style="font-family:Calibri; font-size:12pt">shops, 11,000 supporting events </span><span style="font-family:Calibri; font-size:12pt">such as</span><span style="font-family:Calibri; font-size:12pt"> Race for Life and 7,000 in local fundraising. </span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">They also have a huge impact as interns</span><span style="font-family:Calibri; font-size:12pt"> and</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">campaigni</span><span style="font-family:Calibri; font-size:12pt">ng ambassadors</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt"> </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Transparency</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">9</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">Cancer Research UK prepares its </span><a href="http://www.cancerresearchuk.org/about-us/how-we-are-run/annual-report-and-accounts"><span style="color:#0000ff; font-family:Calibri; font-size:12pt; text-decoration:underline">annual report and accounts</span></a><span style="font-family:Calibri; font-size:12pt"> in compliance with the Statement of Recommended Practice (SORP) for Charities. </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">1</span><span style="font-family:Calibri; font-size:12pt">0</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">Its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">annual report lists the number of employe</span><span style="font-family:Calibri; font-size:12pt">es (approximately 5%) whose gross pay exceeds £60,000 per year, presented in bands of £10,000. The salary bands published within </span><span style="font-family:Calibri; font-size:12pt">the</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">annual report enable donors and other stakeholders to see the proportion of Charity resources dedicated to employee salarie</span><span style="font-family:Calibri; font-size:12pt">s.  </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">1</span><span style="font-family:Calibri; font-size:12pt">1</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">Some of </span><span style="font-family:Calibri; font-size:12pt">the</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">highest paid </span><span style="font-family:Calibri; font-size:12pt">employees</span><span style="font-family:Calibri; font-size:12pt"> are world leading scientists who have contributed to </span><span style="font-family:Calibri; font-size:12pt">major</span><span style="font-family:Calibri; font-size:12pt"> advances in cancer research and continue to do so.  </span><span style="font-family:Calibri; font-size:12pt">Others</span><span style="font-family:Calibri; font-size:12pt"> are senior leaders with the necessary skill and experience to manage </span><span style="font-family:Calibri; font-size:12pt">a</span><span style="font-family:Calibri; font-size:12pt"> comparatively complex </span><span style="font-family:Calibri; font-size:12pt">organisation</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">which,</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">l</span><span style="font-family:Calibri; font-size:12pt">ike other international</span><span style="font-family:Calibri; font-size:12pt"> biomedical organisations</span><span style="font-family:Calibri; font-size:12pt">,</span><span style="font-family:Calibri; font-size:12pt"> demand</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> high quality professional management.  Of the 189 staff members who earn £60,000 per year or more, 105 are involved with scientific work (56%)</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt">  84 are ‘non-scientific’ staff (44%) </span><span style="font-family:Calibri; font-size:12pt">whose work is essential in </span><span style="font-family:Calibri; font-size:12pt">running the organisation and in </span><span style="font-family:Calibri; font-size:12pt">sustaining the</span><span style="font-family:Calibri; font-size:12pt"> fundraising that enables </span><span style="font-family:Calibri; font-size:12pt">the Charity</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">to plan and fund research for the long term</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">Cancer Research UK’s fundraising is a sophisticated marketing</span><span style="font-family:Calibri; font-size:12pt"> operation</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">requir</span><span style="font-family:Calibri; font-size:12pt">ing</span><span style="font-family:Calibri; font-size:12pt"> high calibre leadership. </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Governance</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">1</span><span style="font-family:Calibri; font-size:12pt">2</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">Cancer Research U</span><span style="font-family:Calibri; font-size:12pt">K</span><span style="font-family:Calibri; font-size:12pt"> is a company limited by guarantee and is a registered charity.  It is governed by a Council of Trustees.  This Council is ultimately responsible for the Charity’s strategic direction, supported by a number of committees to which the Council delegates cert</span><span style="font-family:Calibri; font-size:12pt">ain authorities. </span><span style="font-family:Calibri; font-size:12pt">These include </span><span style="font-family:Calibri; font-size:12pt">a </span><span style="font-family:Calibri; font-size:12pt">Nomination, Governance and Remuneration Committee</span><span style="font-family:Calibri; font-size:12pt">, whose role is explained further below.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">The Charity’s governance fully complies with the Code for the Voluntary and Community Sector, endorsed by the Charity Commission.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt"> Co</span><span style="font-family:Calibri; font-size:12pt">uncil delegate</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> day-to-day running of the Charity </span><span style="font-family:Calibri; font-size:12pt">to</span><span style="font-family:Calibri; font-size:12pt"> the Executive Board, which is led by the Chief Executive</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">The governance of </span><span style="font-family:Calibri; font-size:12pt">Cancer Research UK </span><span style="font-family:Calibri; font-size:12pt">is designed to match the</span><span style="font-family:Calibri; font-size:12pt"> standards expected of a FTSE 250 company. </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">13. </span><span style="font-family:Calibri; font-size:12pt">Cancer Research UK’s </span><span style="font-family:Calibri; font-size:12pt">T</span><span style="font-family:Calibri; font-size:12pt">rustees </span><span style="font-family:Calibri; font-size:12pt">perform a</span><span style="font-family:Calibri; font-size:12pt">n essential</span><span style="font-family:Calibri; font-size:12pt"> role in the effective governance of the Charity. </span><span style="font-family:Calibri; font-size:12pt">Trustees do not receive payment for their services but </span><span style="font-family:Calibri; font-size:12pt">are entitled to reclaim </span><span style="font-family:Calibri; font-size:12pt">reasonable expenses for travel and subsistence incurred in attending meetings and events in </span><span style="font-family:Calibri; font-size:12pt">an</span><span style="font-family:Calibri; font-size:12pt"> official cap</span><span style="font-family:Calibri; font-size:12pt">acity.  </span><span style="font-family:Calibri; font-size:12pt">On average, e</span><span style="font-family:Calibri; font-size:12pt">ach </span><span style="font-family:Calibri; font-size:12pt">T</span><span style="font-family:Calibri; font-size:12pt">rustee claimed</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">less than £1,900 </span><span style="font-family:Calibri; font-size:12pt">during</span><span style="font-family:Calibri; font-size:12pt"> the year 2012/13.</span><br /><span style="font-family:Calibri; font-size:12pt; font-style:normal"> </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Recruitment and </span><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Remuneration policy</span><span style="font-family:Calibri; font-size:12pt"> </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">1</span><span style="font-family:Calibri; font-size:12pt">4</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt">Cancer Research UK’s Nomination, Governance and Remuneration Committee </span><span style="font-family:Calibri; font-size:12pt"> has responsibility for oversight of the governance policies and procedures of the Charity and also determines and agrees the overall policy for remuneration and pension arrangements for employees</span><span style="font-family:Calibri; font-size:12pt">.  </span><span style="font-family:Calibri; font-size:12pt">The Committee, whose terms of reference are regularly rev</span><span style="font-family:Calibri; font-size:12pt">iewed, consists entirely of </span><span style="font-family:Calibri; font-size:12pt">T</span><span style="font-family:Calibri; font-size:12pt">rustees.</span><span style="font-family:Calibri; font-size:12pt"> The Committee oversees any major changes in employee benefits includ</span><span style="font-family:Calibri; font-size:12pt">ing</span><span style="font-family:Calibri; font-size:12pt"> review and approval of the remuneration of members of the Executive Board</span><span style="font-family:Calibri; font-size:12pt"> and the Chief Executive</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">It also </span><span style="font-family:Calibri; font-size:12pt">oversee</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> the </span><span style="font-family:Calibri; font-size:12pt">C</span><span style="font-family:Calibri; font-size:12pt">harity’s annual salary re</span><span style="font-family:Calibri; font-size:12pt">view</span><span style="font-family:Calibri; font-size:12pt">.</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">1</span><span style="font-family:Calibri; font-size:12pt">5. The Charity has</span><span style="font-family:Calibri; font-size:12pt"> a series of </span><span style="font-family:Calibri; font-size:12pt">broad salary bands </span><span style="font-family:Calibri; font-size:12pt">appropriate to</span><span style="font-family:Calibri; font-size:12pt"> each grade</span><span style="font-family:Calibri; font-size:12pt"> which do</span><span style="font-family:Calibri; font-size:12pt"> not </span><span style="font-family:Calibri; font-size:12pt">distinguish </span><span style="font-family:Calibri; font-size:12pt">between </span><span style="font-family:Calibri; font-size:12pt">function and</span><span style="font-family:Calibri; font-size:12pt"> specific role types, but allow </span><span style="font-family:Calibri; font-size:12pt">the </span><span style="font-family:Calibri; font-size:12pt">group</span><span style="font-family:Calibri; font-size:12pt">ing of</span><span style="font-family:Calibri; font-size:12pt"> roles of similar skill, professionalism and responsibility</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt">  When </span><span style="font-family:Calibri; font-size:12pt">the Charity</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">consider</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> each role</span><span style="font-family:Calibri; font-size:12pt">,</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">it</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">set</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> a benchmark salary range </span><span style="font-family:Calibri; font-size:12pt">between the median salary of the charity sector and the median of the appropriate</span><span style="font-family:Calibri; font-size:12pt"> private or other</span><span style="font-family:Calibri; font-size:12pt"> sector for that particular role.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">Apart from me</span><span style="font-family:Calibri; font-size:12pt">mbership of one of our pension schemes</span><span style="font-family:Calibri; font-size:12pt">,</span><span style="font-family:Calibri; font-size:12pt"> all of which are contributory, remuneration</span><span style="font-family:Calibri; font-size:12pt"> does not</span><span style="font-family:Calibri; font-size:12pt"> include any additional ben</span><span style="font-family:Calibri; font-size:12pt">efits such as bonuses</span><span style="font-family:Calibri; font-size:12pt">,</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">as</span><span style="font-family:Calibri; font-size:12pt"> typically </span><span style="font-family:Calibri; font-size:12pt">found</span><span style="font-family:Calibri; font-size:12pt"> in the pr</span><span style="font-family:Calibri; font-size:12pt">ivate sector</span><span style="font-family:Calibri; font-size:12pt">. </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">1</span><span style="font-family:Calibri; font-size:12pt">6</span><span style="font-family:Calibri; font-size:12pt">. </span><span style="font-family:Calibri; font-size:12pt">The Charity</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">aim</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> to be competitive in the market</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">so as</span><span style="font-family:Calibri; font-size:12pt"> to attract and retain the best people,</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">whilst always being mindful of the efficient use of donors’ support. </span><span style="font-family:Calibri; font-size:12pt">To achieve this </span><span style="font-family:Calibri; font-size:12pt">it</span><span style="font-family:Calibri; font-size:12pt"> use</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> external agencies and salary </span><span style="font-family:Calibri; font-size:12pt">survey </span><span style="font-family:Calibri; font-size:12pt">databases to ensure that </span><span style="font-family:Calibri; font-size:12pt">it</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">benchmark</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> accurately</span><span style="font-family:Calibri; font-size:12pt">;</span><span style="font-family:Calibri; font-size:12pt"> th</span><span style="font-family:Calibri; font-size:12pt">is approach is</span><span style="font-family:Calibri; font-size:12pt"> reviewed on a regular basis. </span><span style="font-family:Calibri; font-size:12pt">Positions on</span><span style="font-family:Calibri; font-size:12pt"> the Executive Boa</span><span style="font-family:Calibri; font-size:12pt">rd are individually benchmarked. While </span><span style="font-family:Calibri; font-size:12pt">the Charity</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">recognise</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> that </span><span style="font-family:Calibri; font-size:12pt">it</span><span style="font-family:Calibri; font-size:12pt"> should not and do</span><span style="font-family:Calibri; font-size:12pt">es</span><span style="font-family:Calibri; font-size:12pt"> not compete directly with the private sector in terms of remuneration, </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">success in recruiting from th</span><span style="font-family:Calibri; font-size:12pt">e private </span><span style="font-family:Calibri; font-size:12pt">sector is strongly correlated to the breadth, intere</span><span style="font-family:Calibri; font-size:12pt">st and diversity attached to </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">roles. </span><a name="_GoBack"></a></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-style:normal">17.</span><span style="font-family:Calibri; font-size:12pt; font-style:normal"> </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">Recruitment for senior roles</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">consists</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">of assessments</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">by</span><span style="font-family:Calibri; font-size:12pt; font-style:normal"> senior managers and </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">T</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">rustees</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">,</span><span style="font-family:Calibri; font-size:12pt; font-style:normal"> incorporating a</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">technical assessment, as required, to assess specialist capabilities.</span><span style="font-family:Calibri; font-size:12pt; font-style:italic"> </span><span style="font-family:Calibri; font-size:12pt">Where appropriate</span><span style="font-family:Calibri; font-size:12pt">,</span><span style="font-family:Calibri; font-size:12pt; font-style:italic"> </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">external</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">agencies</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">are engaged </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">in</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">the search and selection of candidates.</span><span style="font-family:Calibri; font-size:12pt; font-style:normal"> </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">These agencies</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">support </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">the Charity</span><span style="font-family:Calibri; font-size:12pt; font-style:normal"> </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">in creating robust selection processes that are</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">comparable to those used in the</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">broader</span><span style="font-family:Calibri; font-size:12pt; font-style:normal"> </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">market.</span><span style="font-family:Calibri; font-size:12pt; font-style:normal"> </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">&#xa0;</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">The Charity</span><span style="font-family:Calibri; font-size:12pt; font-style:normal"> </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">seek</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">s</span><span style="font-family:Calibri; font-size:12pt; font-style:normal"> to </span><span style="font-family:Calibri; font-size:12pt; font-style:normal">select</span><span style="font-family:Calibri; font-size:12pt; font-style:normal"> the right candidate for each role, to ens</span><span style="font-family:Calibri; font-size:12pt; font-style:normal">ure that they will add value.</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">18</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">The Cha</span><span style="font-family:Calibri; font-size:12pt">r</span><span style="font-family:Calibri; font-size:12pt">ity’s</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">current policy is not to disclose the remuneration details of individual </span><span style="font-family:Calibri; font-size:12pt">employees;</span><span style="font-family:Calibri; font-size:12pt"> however </span><span style="font-family:Calibri; font-size:12pt">it</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">confirm</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> that </span><span style="font-family:Calibri; font-size:12pt">the</span><span style="font-family:Calibri; font-size:12pt"> highest paid employee is the Chief Executive. </span><span style="font-family:Calibri; font-size:12pt">S</span><span style="font-family:Calibri; font-size:12pt">enior executives do not receive performance related bonuses. </span><br /><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt"><br style="page-break-before:always; clear:both" /></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Appendix</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Improving treatments and developing new ones</span></p><p style="margin:5pt 0pt 5pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">19. Survival</span><span style="font-family:Calibri; font-size:12pt"> rates from cancer have doubled over the last 40 years. The science support</span><span style="font-family:Calibri; font-size:12pt">ed</span><span style="font-family:Calibri; font-size:12pt"> and fund</span><span style="font-family:Calibri; font-size:12pt">ed by Cancer Research UK</span><span style="font-family:Calibri; font-size:12pt"> is at the hea</span><span style="font-family:Calibri; font-size:12pt">rt of these improvements. In 2012/13, </span><span style="font-family:Calibri; font-size:12pt">the Charity</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">spent £351 million on research in institutes, hospitals and universities across the UK. </span><span style="font-family:Calibri; font-size:12pt">It is</span><span style="font-family:Calibri; font-size:12pt"> the only charity that funds research into all types of cancer, across the development pathway from basic biology to large clinical trials. </span><span style="font-family:Calibri; font-size:12pt">The Charity has</span><span style="font-family:Calibri; font-size:12pt"> helped develop life-saving and life-extending cancer treatments, including tamoxifen</span><span style="font-family:Calibri; font-size:12pt"> and Herceptin</span><span style="font-family:Calibri; font-size:12pt"> f</span><span style="font-family:Calibri; font-size:12pt">or breast cancer and abiraterone for prostate cancer.</span></p><p style="margin:5pt 0pt 5pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">20.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">A substantial proportion of Cancer Research UK's scientific funding is provided to </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">five core research institutes in Glasgow, Cambridge, Oxford, Manchester and London. Cancer Research UK is one o</span><span style="font-family:Calibri; font-size:12pt">f the founding partners of the Francis Crick Institute - a world-class centre for interdisciplinary medical sciences, research and innovation, scheduled to open in 2015.  </span></p><p style="margin:5pt 0pt 5pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">21.</span><span style="font-family:Calibri; font-size:12pt"> The Charity</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">also fund</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> work through fifteen Cancer Research UK Centres.  These C</span><span style="font-family:Calibri; font-size:12pt">entres provide a national framework to deliver world-leading research, improved patient care and greater local engagement. They drive local partnerships and high-calibre collaborations between universities, NHS Trusts</span><span style="font-family:Calibri; font-size:12pt">, industry</span><span style="font-family:Calibri; font-size:12pt"> and other cancer charities u</span><span style="font-family:Calibri; font-size:12pt">nder a united strategy to accelerate the translation of research into the clinic for patient benefit. </span></p><p style="margin:0pt 0pt 12pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">22.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">Providing an environment in which world-class research can thrive is crucial to </span><span style="font-family:Calibri; font-size:12pt">a</span><span style="font-family:Calibri; font-size:12pt">chieving </span><span style="font-family:Calibri; font-size:12pt">the Charity’s</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">research goals. </span><span style="font-family:Calibri; font-size:12pt">I</span><span style="font-family:Calibri; font-size:12pt">nvestment in infrastructure </span><span style="font-family:Calibri; font-size:12pt">such as </span><span style="font-family:Calibri; font-size:12pt">in the</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">Centres helps to shape the research environment in the UK so that researchers can make the most of funding from </span><span style="font-family:Calibri; font-size:12pt">Cancer Research UK</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">and others</span><span style="font-family:Calibri; font-size:12pt">.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">It also enables </span><span style="font-family:Calibri; font-size:12pt">the Charity </span><span style="font-family:Calibri; font-size:12pt">to </span><span style="font-family:Calibri; font-size:12pt">nurture the research leaders of the future. </span><span style="font-family:Calibri; font-size:12pt">The Charity</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">support</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> research through </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">involvement in partnerships and networks, both nationally and internationally, as well as funding the work of individual researchers across the UK.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; orphans:0; page-break-after:avoid; page-break-inside:avoid; text-indent:-14.2pt; widows:0"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 10pt 14.2pt; orphans:0; page-break-after:avoid; page-break-inside:avoid; text-indent:-14.2pt; widows:0"><span style="font-family:Calibri; font-size:12pt; font-weight:bold">Arming everyone with vital information</span></p><p style="margin:0pt 0pt 10pt 14.2pt; orphans:0; page-break-after:avoid; page-break-inside:avoid; text-indent:-14.2pt; widows:0"><span style="font-family:Calibri; font-size:12pt">23.</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">In 2012/13 </span><span style="font-family:Calibri; font-size:12pt">the Charity </span><span style="font-family:Calibri; font-size:12pt">also spent £17 mill</span><span style="font-family:Calibri; font-size:12pt">ion on providing information to people affected by cancer, raising awareness of cancer risks and symptoms, and influencing health, science and charity policies.  </span><span style="font-family:Calibri; font-size:12pt">It</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">provide</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> information and communicate</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> with patients and the public about cancer prevention </span><span style="font-family:Calibri; font-size:12pt">and early diagnosis to widen the impact </span><span style="font-family:Calibri; font-size:12pt">of </span><span style="font-family:Calibri; font-size:12pt">its</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">research.  </span><span style="font-family:Calibri; font-size:12pt">It</span><span style="font-family:Calibri; font-size:12pt"> </span><span style="font-family:Calibri; font-size:12pt">also</span><span style="font-family:Calibri; font-size:12pt"> work</span><span style="font-family:Calibri; font-size:12pt">s</span><span style="font-family:Calibri; font-size:12pt"> to influence decision-</span><span style="font-family:Calibri; font-size:12pt">makers to create environments that will lead to faster progress in the fight against cancer. </span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 14.2pt; text-indent:-14.2pt"><span style="font-family:Calibri; font-size:12pt; font-style:italic">December 2013</span></p><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p></div></body></html>